Germline Transmission in Transgenic Huntington's Disease Monkeys

Overview

Journal Theriogenology

Publisher Elsevier

Date 2015 Apr 29

PMID 25917881

Citations 16

Authors

Sean Moran

Tim Chi

Melinda S Prucha

Kwang Sung Ahn

Fawn Connor-Stroud

Sherrie Jean

Kenneth Gould

Anthony W S Chan

Affiliations

Soon will be listed here.

Abstract

Transgenic nonhuman primate models are an increasingly popular model for neurologic and neurodegenerative disease because their brain functions and neural anatomies closely resemble those of humans. Transgenic Huntington's disease monkeys (HD monkeys) developed clinical features similar to those seen in HD patients, making the monkeys suitable for a preclinical study of HD. However, until HD monkey colonies can be readily expanded, their use in preclinical studies will be limited. In the present study, we confirmed germline transmission of the mutant huntingtin (mHTT) transgene in both embryonic stem cells generated from three male HD monkey founders (F0) and in second-generation offspring (F1) produced via artificial insemination by using intrauterine insemination technique. A total of five offspring were produced from 15 females that were inseminated by intrauterine insemination using semen collected from the three HD founders (5 of 15, 33%). Thus far, sperm collected from the HD founder (rHD8) has led to two F1 transgenic HD monkeys with germline transmission rate at 100% (2 of 2). mHTT expression was confirmed by quantitative real-time polymerase chain reaction using skin fibroblasts from the F1 HD monkeys and induced pluripotent stem cells established from one of the F1 HD monkeys (rHD8-2). Here, we report the stable germline transmission and expression of the mHTT transgene in HD monkeys, which suggest possible expansion of HD monkey colonies for preclinical and biomedical research studies.

Citing Articles

Genetically modified non-human primate models for research on neurodegenerative diseases.

Pan M, Zhang H, Li X, Guo X Zool Res. 2024; 45(2):263-274.

PMID: 38287907 PMC: 11017080. DOI: 10.24272/j.issn.2095-8137.2023.197.

Modeling genetic diseases in nonhuman primates through embryonic and germline modification: Considerations and challenges.

Schmidt J, Jones K, Van Vleck T, Emborg M Sci Transl Med. 2022; 14(634):eabf4879.

PMID: 35235338 PMC: 9373237. DOI: 10.1126/scitranslmed.abf4879.

Improved Training and Semen Collection Outcomes Using the Closed Box Chair for Macaques.

Houser L, Ramsey C, de Carvalho F, Kolwitz B, Naito C, Coleman K Animals (Basel). 2021; 11(8).

PMID: 34438841 PMC: 8388729. DOI: 10.3390/ani11082384.

Mending a broken heart: , and models of congenital heart disease.

Rufaihah A, Chen C, Yap C, Mattar C Dis Model Mech. 2021; 14(3).

PMID: 33787508 PMC: 8033415. DOI: 10.1242/dmm.047522.

Generation and Breeding of -Transgenic Marmoset Monkeys: Cell Chimerism and Implications for Disease Modeling.

Drummer C, Vogt E, Heistermann M, Roshani B, Becker T, Matz-Rensing K Cells. 2021; 10(3).

PMID: 33673402 PMC: 7996964. DOI: 10.3390/cells10030505.

References

Snyder B, Cheng P, Yang J, Yang S, Huang A, Chan A . Characterization of dental pulp stem/stromal cells of Huntington monkey tooth germs. BMC Cell Biol. 2011; 12:39. PMC: 3189880. DOI: 10.1186/1471-2121-12-39. View

Ramos E, Cerqueira J, Lemos C, Pinto-Basto J, Alonso I, Sequeiros J . Intergenerational instability in Huntington disease: extreme repeat changes among 134 transmissions. Mov Disord. 2011; 27(4):583-5. DOI: 10.1002/mds.24065. View

Okano H, Hikishima K, Iriki A, Sasaki E . The common marmoset as a novel animal model system for biomedical and neuroscience research applications. Semin Fetal Neonatal Med. 2012; 17(6):336-40. DOI: 10.1016/j.siny.2012.07.002. View

Putkhao K, Kocerha J, Cho I, Yang J, Parnpai R, Chan A . Pathogenic cellular phenotypes are germline transmissible in a transgenic primate model of Huntington's disease. Stem Cells Dev. 2012; 22(8):1198-205. PMC: 3613972. DOI: 10.1089/scd.2012.0469. View

Laowtammathron C, Chan A . Pluripotent hybrid stem cells from transgenic Huntington's disease monkey. Methods Mol Biol. 2013; 1010:61-77. DOI: 10.1007/978-1-62703-411-1_5. View

Semaka A, Kay C, Doty C, Collins J, Bijlsma E, Richards F . CAG size-specific risk estimates for intermediate allele repeat instability in Huntington disease. J Med Genet. 2013; 50(10):696-703. DOI: 10.1136/jmedgenet-2013-101796. View

Higham C, Monckton D . Modelling and inference reveal nonlinear length-dependent suppression of somatic instability for small disease associated alleles in myotonic dystrophy type 1 and Huntington disease. J R Soc Interface. 2013; 10(88):20130605. PMC: 3785826. DOI: 10.1098/rsif.2013.0605. View

Pouladi M, Morton A, Hayden M . Choosing an animal model for the study of Huntington's disease. Nat Rev Neurosci. 2013; 14(10):708-21. DOI: 10.1038/nrn3570. View

Chan A . Progress and prospects for genetic modification of nonhuman primate models in biomedical research. ILAR J. 2013; 54(2):211-23. PMC: 3814401. DOI: 10.1093/ilar/ilt035. View

10.

Niu Y, Shen B, Cui Y, Chen Y, Wang J, Wang L . Generation of gene-modified cynomolgus monkey via Cas9/RNA-mediated gene targeting in one-cell embryos. Cell. 2014; 156(4):836-43. DOI: 10.1016/j.cell.2014.01.027. View

11.

Chan A, Xu Y, Jiang J, Rahim T, Zhao D, Kocerha J . A two years longitudinal study of a transgenic Huntington disease monkey. BMC Neurosci. 2014; 15:36. PMC: 4015530. DOI: 10.1186/1471-2202-15-36. View

12.

Liu H, Chen Y, Niu Y, Zhang K, Kang Y, Ge W . TALEN-mediated gene mutagenesis in rhesus and cynomolgus monkeys. Cell Stem Cell. 2014; 14(3):323-328. PMC: 4024384. DOI: 10.1016/j.stem.2014.01.018. View

13.

Chen Y, Carter R, Cho I, Chan A . Cell-based therapies for Huntington's disease. Drug Discov Today. 2014; 19(7):980-4. PMC: 4082729. DOI: 10.1016/j.drudis.2014.02.012. View

14.

Kocerha J, Liu Y, Willoughby D, Chidamparam K, Benito J, Nelson K . Longitudinal transcriptomic dysregulation in the peripheral blood of transgenic Huntington's disease monkeys. BMC Neurosci. 2013; 14:88. PMC: 3751855. DOI: 10.1186/1471-2202-14-88. View

15.

Morton A, Howland D . Large genetic animal models of Huntington's Disease. J Huntingtons Dis. 2014; 2(1):3-19. DOI: 10.3233/JHD-130050. View

16.

Baxa M, Hruska-Plochan M, Juhas S, Vodicka P, Pavlok A, Juhasova J . A transgenic minipig model of Huntington's Disease. J Huntingtons Dis. 2014; 2(1):47-68. DOI: 10.3233/JHD-130001. View

17.

Carter R, Chen Y, Kunkanjanawan T, Xu Y, Moran S, Putkhao K . Reversal of cellular phenotypes in neural cells derived from Huntington's disease monkey-induced pluripotent stem cells. Stem Cell Reports. 2014; 3(4):585-93. PMC: 4223707. DOI: 10.1016/j.stemcr.2014.07.011. View

18.

Rozen S, Skaletsky H . Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol. 1999; 132:365-86. DOI: 10.1385/1-59259-192-2:365. View

19.

Sackett G, Ruppenthal G, Davis A . Survival, growth, health, and reproduction following nursery rearing compared with mother rearing in pigtailed monkeys (Macaca nemestrina). Am J Primatol. 2002; 56(3):165-83. DOI: 10.1002/ajp.1072. View

20.

Ranen N, Stine O, Abbott M, Sherr M, Codori A, Franz M . Anticipation and instability of IT-15 (CAG)n repeats in parent-offspring pairs with Huntington disease. Am J Hum Genet. 1995; 57(3):593-602. PMC: 1801258. View